N-Formyl-MDMA:
598
Świst, M; Wilamowski, J; Zuba, D; Kochana, J; Parczewski, A. Determination of synthesis route of 1-(3,4-methylenedioxyphenyl)-2-propanone (MDP-2-P) based on impurity profiles of MDMA. Forensic Sci. Int., 10 May 2005, 149 (2–3), 181–192. 594 kB. https://doi.org/10.1016/j.forsciint.2004.06.016
Clark, CR. Synthesis and analytical profiles for regioisomeric and isobaric amines related to MDMA, MDEA and MBDB: Differentiation of drug and non-drug substances of mass spectral equivalence, US DOJ, 1 Oct 2011. 3.9 MB. #9.3-A
King, LA. New phenethylamines in Europe. Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
King, LA. Designer drugs related to amphetamine (1990–1996). JCLIC, 1 Jul 1996, 6 (3), 15-16. 562 kB. #7
Plummer, CM; Breadon, TW; Pearson, JR; Jones, OAH. The synthesis and characterisation of MDMA derived from a catalytic oxidation of material isolated from black pepper reveals potential route specific impurities. Sci. Justice, 1 May 2016, 56 (3), 223–230. 630 kB. https://doi.org/10.1016/j.scijus.2016.01.003 #21 GC,NMR
Butylone · MDMBP · bk-MBDB
N,N-Dimethyl MDCATH · DMONE · bk-MDDMA
EtONE · Ethylone · bk-MDEA
3,4-EDMC · EDMC · βk-EDMA
4-PA NS · 4-Propoxy-β-methyl-β-nitrostyrene
2,6-Me-4-EPEA NS · 4-Ethoxy-2,6-dimethyl-β-nitrostyrene
2-Ethoxy-4,6-dimethyl-β-nitrostyrene · 4,6-Me-2-EPEA
2-EtO-β-Et-NS · 2-Ethoxy-β-ethyl-β-nitrostyrene
2-Methyl-6,7-dimethoxy-8-hydroxy-3,4-dihydroisoquinolinium inner salt